Neurogenic Small Molecules Reverse miR-342-3p-Mediated Tumorigenesis in Renal Cell Carcinoma
World Journal of Oncology · 2026-08 · 17 (4) · 442-453
DOI: 10.14740/wjon2753 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Oncology, 2026-08. Verfasst von Yi Zhou Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hangzhou First People's Hospital Tonglu Hospital, Tonglu County, Hangzhou, Zhejiang, 311500, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Hangzhou First People's Hospital Tonglu Hospital, Tonglu County, Hangzhou, Zhejiang, 311500, China.
- Department of Obstetrics and Gynecology, Hangzhou First People's Hospital Tonglu Hospital, Tonglu County, Hangzhou, Zhejiang, 311500, China.
Zitieren
APA
Ye, Y. Z., Du, Z. M., Chen, H. W., & Xu, Q. (2026). Neurogenic Small Molecules Reverse miR-342-3p-Mediated Tumorigenesis in Renal Cell Carcinoma. World Journal of Oncology, 17(4), 442-453. https://doi.org/10.14740/wjon2753
Vancouver
Ye YZ, Du ZM, Chen HW, Xu Q. Neurogenic Small Molecules Reverse miR-342-3p-Mediated Tumorigenesis in Renal Cell Carcinoma. World Journal of Oncology. 2026;17(4):442-453. doi:10.14740/wjon2753
BibTeX
@article{Ye2026,
author = {Ye, Yi Zhou and Du, Zhang Ming and Chen, Hong Wei and Xu, Qian},
title = {Neurogenic Small Molecules Reverse miR-342-3p-Mediated Tumorigenesis in Renal Cell Carcinoma},
journal = {World Journal of Oncology},
year = {2026},
volume = {17},
number = {4},
pages = {442--453},
doi = {10.14740/wjon2753}
}
EUVIMED